# Transcend Biologics, LLC – FDA Inspection, Aug 14, 2026

Source: https://www.keypedia.com/records/fda_inspections/transcend-biologics-llc/c8a4be29-f8eb-478f-965d-9448f8d96195
Source feed: FDA_Inspections

> FDA inspection 1331790 of Transcend Biologics, LLC, August 14, 2026. 2 citations. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1331790
- Company Name: Transcend Biologics, LLC
- Inspection Date: 2026-08-14
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 2

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/michelle-paxon/1748c593-7d85-4ede-a5f4-8c0a33c21d52)
- [Company Rep](https://www.keypedia.com/people/richard-t-riggie/d07a4551-08b4-44f7-b7d2-02ae3c5dc1e2)

Company: https://www.keypedia.com/companies/transcend-biologics-llc/a0674d8b-5b68-451c-8520-e313b96a4689

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9